Seminars in Nuclear Medicine
Volume 40, Issue 4 , Pages 242-256 , July 2010

Nonosseous, Nonurologic Uptake on Bone Scintigraphy: Atlas and Analysis

  • Lionel S. Zuckier, MD

      Affiliations

    • New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ
    • Corresponding Author InformationAddress reprint requests to Lionel S. Zuckier, MD, Department of Radiology, University Hospital, H-125 150 Bergen Street, Newark, NJ
    • ,
  • Leonard M. Freeman, MD

      Affiliations

    • Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY

References 

  1. Scharf S. SPECT/CT imaging in general orthopedic practice. Semin Nucl Med. 2009;39:293–307
  2. Beheshti M, Langsteger W, Fogelman I. Prostate cancer: Role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:396–407
  3. Ben-Haim S, Israel O. Breast cancer: Role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:408–415
  4. Chua S, Gnanasegaran G, Cook GJ. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): Role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:416–430
  5. Leffers D, Collins L. An overview of the use of bone scintigraphy in sports medicine. Sports Med Arthrosc. 2009;17:21–24
  6. Van Der Bruggen W, Bleeker-Rovers CP, Boerman OC, et al. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: A systematic review. Semin Nucl Med. 2010;40:3–15
  7. Vieras F, Boyd CM. Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J Nucl Med. 1975;16:1109–1114
  8. Gentili A, Miron SD, Adler LP, et al. Incidental detection of urinary tract abnormalities with skeletal scintigraphy. Radiographics. 1991;11:571–579
  9. Maher FT. Evaluation of renal and urinary tract abnormalities noted on scintiscans: A retrospective study of 1,711 radioisotope skeletal surveys performed in an 18-month period. Mayo Clin Proc. 1975;50:370–378
  10. Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: A pathophysiologic approach. Radiographics. 1993;13:715–734
  11. Gentili A, Miron SD, Bellon EM. Nonosseous accumulation of bone-seeking radiopharmaceuticals. Radiographics. 1990;10:871–881
  12. Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans. J Nucl Med Technol. 2003;31:149–153quiz:154-146
  13. Gnanasegaran G, Cook G, Adamson K, et al. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med. 2009;39:380–395
  14. Kaye J, Hayward M. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: Pictorial review. Australas Radiol. 2002;46:13–21
  15. In:  Yun RU,  Alvai A,  Collier BD, et al. editor. Atlas of Nuclear Medicine Artifacts and Variants (ed 2). Chicago, IL: Year Book Medical Publishers; 1990;
  16. Silberstein E, Mcafee J, Spasoff A. Diagnostic Patterns in Nuclear Medicine. Reston, VA: Society of Nuclear Medicine; 1998;
  17. In:  Datz F editors. Gamuts in Nuclear Medicine (ed 3). St. Louis, MO: Mosby; 1995;
  18. In:  Citrin D,  Mckillop J editor. Atlas of Technetium Bone Scans. Philadelphia, PA: W. B. Saunders (WB) Co Ltd; 1978;
  19. Heck LL. Extra-osseous localization of phosphate bone agents. Semin Nucl Med. 1980;10:311–313
  20. Chaudhuri TK. Bone imaging—Tracer uptake in non-neoplastic osseous and nonosseous disease processes. Semin Nucl Med. 1983;13:78–81
  21. Lin DS. Left upper quadrant increased uptake in bone imaging. Semin Nucl Med. 1983;13:179–180
  22. Ackerman L, Elam E, Bushnell D, et al. Bowel visualization in bone scintigraphy. Semin Nucl Med. 1987;17:81–82
  23. Shukla LW, Lin DS, Kutka N. Splenic uptake in bone imaging. Semin Nucl Med. 1988;18:71–73
  24. Goldfarb CR, Ongseng F, Kuhn M, et al. Non-skeletal accumulation of bone seeking agents: Pelvis. Semin Nucl Med. 1988;18:159–161
  25. Lin DS. Uniappendicular increased uptake in bone imaging. Semin Nucl Med. 1988;18:165–166
  26. Lin DS. Increased uptake in the lower neck on bone images. Semin Nucl Med. 1988;18:167–168
  27. Ibis E, Krasnow ZA, Isitman AT, et al. Liver uptake of technetium-99m-labeled phosphate compounds: An updated gamut, 1992. Semin Nucl Med. 1992;22:202–205
  28. Hung GU, Tsai SC, Kao CH, et al. Incidental finding of pancreatic calcification on bone scan. Semin Nucl Med. 2000;30:231–233
  29. Tsai SC, Kao CH, Lin WY, et al. Unusual intestinal and urinary tract accumulation on bone scan: A case with Indiana pouch. Semin Nucl Med. 2000;30:310–312
  30. Tuncel M, Erbas B, Mahmoudian B. Gamut: Soft tissue uptake of bone radiopharmaceuticals. Semin Nucl Med. 2003;33:334–337
  31. Harwood SJ, Wang TY, Camblin JG, et al. Intense focal uptake of technetium-99m diphosphonate in a soft tissue mass. Semin Nucl Med. 1991;21:335–338
  32. Pacheco EM, Civelek AC, Natarajan TK, et al. Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants (A primate model). Arch Ophthalmol. 1997;115:1173–1177
  33. Thrall JH, Ghaed N, Geslien GE, et al. Pitfalls in Tc99m polyphosphate skeletal imaging. Am J Roentgenol Radium Ther Nucl Med. 1974;121:739–747
  34. Kawase T, Fujii H, Nakahara T, et al. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer. Clin Nucl Med. 2009;34:173–174
  35. Coolens JL, Devos P, De Roo M. Diffuse pulmonary uptake of 99mTc bone-imaging agents: Case report and survey. Eur J Nucl Med. 1985;11:36–42
  36. Chaudhuri TK. Liver uptake of 99mTc-diphosphonate. Radiology. 1976;119:485–486
  37. Zimmer AM, Pavel DG. Experimental investigations of the possible cause of liver appearance during bone scanning. Radiology. 1978;126:813–816
  38. Subramanian G, Mcafee JG. A new complex of 99mTc for skeletal imaging. Radiology. 1971;99:192–196
  39. Bull U, Pfeifer JP, Niendorf HP, et al. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging. Br J Radiol. 1977;50:629–636
  40. Davis MA, Jones AL. Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging. Semin Nucl Med. 1976;6:19–31
  41. Galasko CS. Mechanism of uptake of bone imaging isotopes by skeletal metastases. Clin Nucl Med. 1980;5:565–568
  42. In:  Saha G editors. Fundamentals of Nuclear Pharmacy (ed 5). New York, NY: Springer; 2004;
  43. Vallabhajosula S, Owunwanne A. Pathophysiology and mechanisms of radiopharmaceutical localization. In:  Elgazzar A editors. The Pathophysiologic Basis of Nuclear Medicine. Berlin: Germany, Springer-Verlag Berlin Heidelberg; 2006;
  44. In:  Kumar V,  Abbas AK,  Fausto N, et al. editor. Robbins and Cotran Pathologic Basis of Disease (ed 8). Philadelphia, PA: W.B. Saunders; 2010;
  45. Desai A, Eymontt M, Alavi A, et al. 99mTc-MDP uptake in nonosseous lesions. Radiology. 1980;135:181–184
  46. Silberstein EB, Delong S. Femoral artery calcification (Detection by bone scintigraphy). Clin Nucl Med. 1985;10:738–739
  47. Silberstein EB, Clark RA, Delong S. Clinical and radiographic correlates of femoral artery visualization on bone scan. Int J Rad Appl Instrum B. 1989;16:709–713
  48. Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet. 2006;79:650–656
  49. Tachibana T, Hagiwara K, Johkoh T. Pulmonary alveolar microlithiasis: Review and management. Curr Opin Pulm Med. 2009;15:486–490
  50. Shah TC, Talwar A, Shah RD, et al. Pulmonary alveolar microlithiasis: Radiographic and scintigraphic correlation. Clin Nucl Med. 2007;32:249–251
  51. Meissner A, Mamoulakis C, de la Rosette JJ, et al. Clinical update on testicular microlithiasis. Curr Opin Urol. 2009;19:615–618
  52. In:  Baker S,  Cho K,  Stamford C editor. The Abdominal Plain Film with Correlative Imaging. Stamford, CT: Appleton & Lange; 1998;
  53. Lentle BC, Percy JS, Rigal WM, et al. Localization of Tc-99m pyrophosphate in muscle after exercise. J Nucl Med. 1978;19:223–224
  54. Winter PF. Letter: Splenic accumulation of 99mTc-diphosphonate. J Nucl Med. 1976;17:850
  55. Moallem A, Lichsztral R. Deep vein thrombosis detection by 99m TC-MDP scanning. Angiology. 1984;35:515–518
  56. Zuckier LS, Patel KA, Wexler JP, et al. The hot clot sign (A new finding in deep venous thrombosis on bone scintigraphy). Clin Nucl Med. 1990;15:790–793
  57. Karanauskas S, Starshak RJ, Sty JR. Heterotopic Tc-99m MDP uptake secondary to phlebitis. Clin Nucl Med. 1991;16:329–331
  58. Byun HH, Rodman SG, Chung KE. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J Nucl Med. 1976;17:374–375
  59. Van Antwerp JD, Hall JN, O'Mara RE. Soft-tissue concentration of Tc-99m phosphates associated with injections of iron dextran complex. J Nucl Med. 1977;18:855
  60. Hashimoto T, Koizumi K, Hanawa N, et al. Extraosseous skin and subcutaneous tissue uptake of Tc-99m HMDP in a surgical scar after laparotomy. Clin Nucl Med. 2003;28:1000–1001
  61. Brown M, Swift TR, Spies SM. Radioisotope scanning in inflammatory muscle disease. Neurology. 1976;26:517–520
  62. Vanantwerp JD, O'Mara RE, Pitt MJ, et al. Technetium-99m-diphosphonate accumulation in amyloid. J Nucl Med. 1975;16:238–240
  63. Worsley DF, Lentle BC. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. J Nucl Med. 1993;34:1612–1615
  64. Romyn AM, Bushnell DL, Freeman ML, et al. Visualization of metastatic liver disease on technetium-99m bone scintigraphy. Clin Nucl Med. 1987;12:264–267
  65. Berg GR, Kalisher L, Osmond JD, et al. 99mTc-diphosphonate concentration in primary breast carcinoma. Radiology. 1973;109:393–394
  66. Mcdougall IR, Pistenma DA. Concentration of 99mTc diphosphonate in breast tissue. Radiology. 1974;112:655–657
  67. Charkes ND, Makler PT. Studies in skeletal tracer kinetics (V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: Concise communication). J Nucl Med. 1981;22:601–605
  68. Makler PT, Charkes ND. Studies of skeletal tracer kinetics (IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging). J Nucl Med. 1980;21:641–645
  69. Sagar VV, Piccone JM, Charkes ND. Studies of skeletal tracer kinetics (III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow). J Nucl Med. 1979;20:1257–1261
  70. Yu JQ, Zhuang H, Posteraro A, et al. Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis. Clin Nucl Med. 2005;30:742–743
  71. Borzutzky CA, Spinuzza TJ, Turbiner EH. Technetium-99m MDP accumulation in malignant ascites. Clin Nucl Med. 1985;10:731–732
  72. Lamki L, Cohen P, Driedger A. Malignant pleural effusion and Tc-99m MDP accumulation. Clin Nucl Med. 1982;7:331–333
  73. Sandler ED, Hattner RS, Parisi MT, et al. Clinical utility of bone scan features of pleural effusion: Sensitivity and specificity for malignancy based on pleural fluid cytopathology. J Nucl Med. 1994;35:429–431
  74. Siegel ME, Walker WJ, Campbell JL. Accumulation of 99mTc diphosphonate in malignant pleural effusions: Detection and verification. J Nucl Med. 1975;16:883–885
  75. Cole TJ, Balseiro J, Lippman HR. Technetium-99m-methylene diphosphonate (MDP) uptake in a sympathetic effusion: An index of malignancy and a review of the literature. J Nucl Med. 1991;32:325–327
  76. Lee KH, Chung JK, Lee DS, et al. Intestinal leakage of technetium-99m-MDP in primary intestinal lymphangiectasia. J Nucl Med. 1996;37:639–641
  77. Roach PJ, Itrato D, Treves ST. Bowel visualization on bone scan because of protein losing enteropathy. Clin Nucl Med. 1994;19:1114–1116
  78. Lee VW, Leiter BE, Weitzman F, et al. Occult gastric bleeding demonstrated by bone scan and Tc-99m-DTPA renal scan. Clin Nucl Med. 1981;6:470–473
  79. Sherkow L, Ryo UY, Fabich D, et al. Visualization of the liver, gallbladder, and intestine on bone scintigraphy. Clin Nucl Med. 1984;9:440–443
  80. Bhatnagar P, Chakraborti KL, Sachdev P, et al. Serendipitous gallbladder uptake in a bone scan. Clin Nucl Med. 2005;30:512–513
  81. Ergun EL, Kiratli PO, Gunay EC, et al. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature. Nucl Med Commun. 2006;27:877–885
  82. Conway JJ, Weiss SC, Khentigan A, et al. Gallbladder and bowel localization of bone imaging radiopharmaceuticals. J Nucl Med. 1979;20:622
  83. Wallis JW, Fisher S, Wahl RL. 99Tcm-MDP uptake by lymph nodes following tracer infiltration: Clinical and laboratory evaluation. Nucl Med Commun. 1987;8:357–363
  84. Chatterton BE, Vannitamby M, Cook DJ. Lymph node visualisation: An unusual artefact in the 99mTc-pyrophosphate bone scan. Eur J Nucl Med. 1980;5:187–188
  85. Dogan AS, Rezai K. Incidental lymph node visualization on bone scan due to subcutaneous infiltration of Tc-99m MDP (A potential for false positive interpretation). Clin Nucl Med. 1993;18:208–209
  86. Penney HF, Styles CB. Fortuitous lymph node visualization after interstitial injection of Tc-99m-MDP. Clin Nucl Med. 1982;7:84–85
  87. Suga K, Ohono Y, Yoneshiro S, et al. A case of squamous cell carcinoma of urinary bladder with an ileo-vesical fistula detected on bone scintigraphy [in Japanese]. Kaku Igaku. 1992;29:105–110
  88. Mochizuki T, Kawai H, Nishimura T, et al. Uriposia after intravenous administration of technetium-99m HMDP. Clin Nucl Med. 1993;18:435–436
  89. Kosuda S, Katagiri S, Ka WJ, et al. Demonstration of the ascending colon on Tc-99m MDP skeletal imaging: Pitfall in bone scanning by a faith cure of drinking urine. Clin Nucl Med. 2000;25:1040–1041
  90. Tsai SC, Kao CH, Lin WY, et al. Intestinal accumulation of Tc 99m MDP on bone scan. Semin Nucl Med. 1999;29:80–81
  91. Wang YF, Cherng SC, Cheng CY, et al. Colon visualization of bone scan: A special and interesting case. Clin Nucl Med. 1998;23:723–724

PII: S0001-2998(10)00014-0

doi: 10.1053/j.semnuclmed.2010.02.003

Seminars in Nuclear Medicine
Volume 40, Issue 4 , Pages 242-256 , July 2010

Article Tools

* Image Usage & Resolution